$QBTS Balance Sheet | Understand Stock

$QBTS

$12.14 +$0.60 (5.16%) Live

$QBTS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022
Assets
Current assets:
Cash
Cash and cash equivalents
Marketable investment securities
Trade accounts receivable, net of allowance for credit losses of $1 and $176
Research incentive receivable
Inventories
Prepaid expenses and other current assets
Deferred offering costs
Total current assets

Property and equipment, net
Operating lease right-of-use assets
Intangible assets, net
Goodwill
Other non-current assets, net
Total assets
Liabilities and stockholders' equity
Current liabilities:
Trade accounts payable
Accrued expenses and other current liabilities
Loans payable, current
Current portion of operating lease liabilities
Loans payable, net, current
Deferred revenue, current
Promissory notes - related party
Total current liabilities
Warrant liabilities
Operating lease liabilities, net of current portion
Loans payable, net, non-current
Deferred revenue, non-current
Other noncurrent liabilities
Total liabilities
Stockholders' equity:
Non-redeemable convertible preferred stock*, no par value; nil shares and 122,564,333 shares authorized as of December 31, 2022 and December 31, 2021, respectively; nil shares and 122,564,333 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively.
Common stock, par value $0.0001 per share; 675,000,000 shares authorized at both June 30, 2026 and December 31, 2025; 372,011,420 shares and 358,741,605 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively.
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders' equity

Total liabilities and stockholders’ equity

Common stock, authorized (in shares)

Comments